Literature DB >> 25791278

Citrate versus acetate-based dialysate in on-line haemodiafiltration. A prospective cross-over study.

Manuel Molina Nuñez, Rosa de Alarcón, Susana Roca, Gracia Álvarez, María Soledad Ros, Cristina Jimeno, Laura Bucalo, Isabel Villegas, María Ángeles García.   

Abstract

BACKGROUND AND AIMS: A bicarbonate dialysate acidified with citrate (CD) has been reported to have local anticoagulant effect and improves biocompatibility. This study examines the effect of CD on dialysis efficiency, coagulation, acid-base status, electrolytes, and inflammation in patients in on-line hemodiafiltration (OL-HDF).
METHODS: 35 patients in OL-HDF were enrolled in a prospective, cross-over study for a 24-week period and two phases alternating CD and acetate dialysate fluid (AD). Parameters on study were predialysis levels of bicarbonate and ionic calcium, reactive C Protein (CRP), and beta-2 microglobulin (B2MG) and postdialysis levels of activated tromboplastine time, bicarbonate, and ionized calcium.
RESULTS: No significant differences in coagulation parameters, pH, and predialysis bicarbonate were found. The postdialysis bicarbonate and postdialysis calcium were lower with CD. Dialysis efficiency was greater with CD. Regarding inflammatory parameters, both CRP and B2MG were lower using CD.
CONCLUSION: The use of CD is safe and effective in OL-HDF, and it improves dialysis efficacy, postdialysis alkalosis, and inflammation.
© 2015 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25791278     DOI: 10.1159/000371569

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  6 in total

Review 1.  Bicarbonate Balance and Prescription in ESRD.

Authors:  Matthew K Abramowitz
Journal:  J Am Soc Nephrol       Date:  2016-11-23       Impact factor: 10.121

2.  Citrate high volume on-line hemodiafiltration modulates serum Interleukin-6 and Klotho levels: the multicenter randomized controlled study "Hephaestus".

Authors:  Francesco Pizzarelli; Vincenzo Cantaluppi; Vincenzo Panichi; Alessandro Toccafondi; Giuseppe Ferro; Serena Farruggio; Elena Grossini; Pietro Claudio Dattolo; Vincenzo Miniello; Massimiliano Migliori; Cristina Grimaldi; Aldo Casani; Maurizio Borzumati; Stefano Cusinato; Alessandro Capitanini; Alessandro Quercia; Oliviero Filiberti; Lucia Dani
Journal:  J Nephrol       Date:  2021-02-09       Impact factor: 3.902

3.  Is Anticoagulation Discontinuation Achievable with Citrate Dialysate during HDF Sessions?

Authors:  Thibault Dolley-Hitze; Emmanuel Oger; Didier Hamel; Marie-Laure Lombart; Isabelle Hermès
Journal:  Int J Nephrol       Date:  2016-10-10

4.  Citric-acid dialysate improves the calcification propensity of hemodialysis patients: A multicenter prospective randomized cross-over trial.

Authors:  Karlien J Ter Meulen; Marijke J E Dekker; Andreas Pasch; Natascha J H Broers; Frank M van der Sande; Jeroen B van der Net; Constantijn J A M Konings; Isabelle M Gsponer; Matthias D N Bachtler; Adelheid Gauly; Bernard Canaud; Jeroen P Kooman
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

5.  A high magnesium concentration in citrate dialysate prevents oxidative stress and damage in human monocytes in vitro.

Authors:  Carmen Vida; Julia Carracedo; Patricia de Sequera; Guillermo Bodega; Rafael Pérez; Matilde Alique; Rafael Ramírez
Journal:  Clin Kidney J       Date:  2020-08-30

6.  Impact of acetate- or citrate-acidified bicarbonate dialysate on ex vivo aorta wall calcification.

Authors:  Ricardo Villa-Bellosta; Eduardo Hernández-Martínez; Eva Mérida-Herrero; Emilio González-Parra
Journal:  Sci Rep       Date:  2019-08-06       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.